{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:07:09Z","timestamp":1769609229533,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Project of Jiangxi Provincial Department of Education","award":["GJJ2400117"],"award-info":[{"award-number":["GJJ2400117"]}]},{"name":"Science and Technology Plan of Jiangxi Provincial Health Commission","award":["202510373"],"award-info":[{"award-number":["202510373"]}]},{"name":"Science and Technology Program of Jiangxi Province","award":["2025BAC200519"],"award-info":[{"award-number":["2025BAC200519"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82460609"],"award-info":[{"award-number":["82460609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01719-6","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:29:07Z","timestamp":1762241347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DDX1 facilitates lenvatinib resistance in hepatocellular carcinoma through regulating ephrin-A3 and activating the Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1007","volume":"25","author":[{"given":"Shenglan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"10","key":"1719_CR1","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/genes12101471","volume":"12","author":"M Cargill","year":"2021","unstructured":"Cargill M, Venkataraman R, Lee S (2021) DEAD-box RNA helicases and genome stability. Genes 12(10):1471. https:\/\/doi.org\/10.3390\/genes12101471","journal-title":"Genes"},{"issue":"12","key":"1719_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13325","volume":"55","author":"L Chen","year":"2022","unstructured":"Chen L, Liu Z, Tang H, Zhou Z, Chen J, Ma Z et al (2022) Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer. Cell Prolif 55(12):e13325","journal-title":"Cell Prolif"},{"issue":"1","key":"1719_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1311-z","volume":"38","author":"L Deng","year":"2019","unstructured":"Deng L, Sun J, Chen X, Liu L, Wu D (2019) Nek2 augments Sorafenib resistance by regulating the ubiquitination and localization of \u03b2-catenin in hepatocellular carcinoma. J Exp Clin Cancer Res 38(1):316","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1719_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12935-021-02226-x","volume":"21","author":"M Deng","year":"2021","unstructured":"Deng M, Tong R, Zhang Z, Wang T, Liang C, Zhou X et al (2021) EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma. Cancer Cell Int 21(1):535","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1719_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02225-9","volume":"23","author":"R Devasahayam Arokia Balaya","year":"2025","unstructured":"Devasahayam Arokia Balaya R, Kanekar S, Kumar S, Kandasamy RK (2025) Role of DEAD\/DEAH-box helicases in immunity, infection and cancers. Cell Commun Signal 23(1):292","journal-title":"Cell Commun Signal"},{"key":"1719_CR6","doi-asserted-by":"crossref","unstructured":"Dolde C, Bischof J, Gr\u00fcter S, Montada A, Halekotte J, Peifer C et al (2018) A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1\u03b5. J Cell Sci 131(1):jcs207316.","DOI":"10.1242\/jcs.207316"},{"issue":"8","key":"1719_CR7","doi-asserted-by":"publisher","first-page":"104069","DOI":"10.1016\/j.drudis.2024.104069","volume":"29","author":"FM Fan","year":"2024","unstructured":"Fan FM, Fleishman JS, Chen J, Chen ZS, Dong HH (2024) New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma. Drug Discov Today 29(8):104069","journal-title":"Drug Discov Today"},{"issue":"782","key":"1719_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abp8923","volume":"16","author":"E Fatti","year":"2023","unstructured":"Fatti E, Hirth A, \u0160vorini\u0107 A, G\u00fcnther M, Stier G, Cruciat CM et al (2023) Dead box RNA helicases act as nucleotide exchange factors for casein kinase 2. Sci Signal 16(782):eabp8923","journal-title":"Sci Signal"},{"issue":"26","key":"1719_CR9","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/JCO.20.00808","volume":"38","author":"RS Finn","year":"2020","unstructured":"Finn RS, Ikeda M, Zhu AX, Sung MW, Baron AD, Kudo M et al (2020) Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma. J Clin Oncol 38(26):2960\u20132970","journal-title":"J Clin Oncol"},{"issue":"6","key":"1719_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1101\/gr.278264.123","volume":"34","author":"A Hirth","year":"2024","unstructured":"Hirth A, Fatti E, Netz E, Acebron SP, Papageorgiou D, \u0160vorini\u0107 A et al (2024) Dead box RNA helicases are pervasive protein kinase interactors and activators. Genome Res 34(6):952\u2013966","journal-title":"Genome Res"},{"issue":"21","key":"1719_CR11","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/onc.2013.238","volume":"33","author":"J Huang","year":"2014","unstructured":"Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W et al (2014) Epha2 promotes epithelial-mesenchymal transition through the Wnt\/\u03b2-catenin pathway in gastric cancer cells. Oncogene 33(21):2737\u20132747","journal-title":"Oncogene"},{"key":"1719_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.943384","volume":"9","author":"S Huang","year":"2022","unstructured":"Huang S, Dong C, Zhang J, Fu S, Lv Y, Wu J (2022) A comprehensive prognostic and immunological analysis of Ephrin family genes in hepatocellular carcinoma. Front Mol Biosci 9:943384","journal-title":"Front Mol Biosci"},{"issue":"1","key":"1719_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85737-1","volume":"15","author":"S Huang","year":"2025","unstructured":"Huang S, Liu K, Xu Y, Wang H, Fu S, Wu J (2025) hsa_circ_0008305 facilitates the malignant progression of hepatocellular carcinoma by regulating AKR1C3 expression and sponging miR-379-5p. Sci Rep 15(1):1309","journal-title":"Sci Rep"},{"issue":"2","key":"1719_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jhep.2022.02.018","volume":"77","author":"A Husain","year":"2022","unstructured":"Husain A, Chiu YT, Sze KM, Ho DW, Tsui YM, Suarez EMS et al (2022) Ephrin-A3\/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. J Hepatol 77(2):383\u2013396. https:\/\/doi.org\/10.1016\/j.jhep.2022.02.018","journal-title":"J Hepatol"},{"key":"1719_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.639779","volume":"9","author":"M Karabicici","year":"2021","unstructured":"Karabicici M, Azbazdar Y, Ozhan G, Senturk S, Firtina Karagonlar Z, Erdal E (2021) Changes in Wnt and TGF-\u03b2 signaling mediate the development of regorafenib resistance in hepatocellular carcinoma cell line HuH7. Front Cell Dev Biol 9:639779","journal-title":"Front Cell Dev Biol"},{"issue":"10126","key":"1719_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F et al (2018) Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 391(10126):1163\u20131173","journal-title":"Lancet"},{"issue":"22","key":"1719_CR17","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1128\/MCB.00415-16","volume":"36","author":"L Li","year":"2016","unstructured":"Li L, Germain DR, Poon HY, Hildebrandt MR, Monckton EA, McDonald D et al (2016) DEAD box 1 facilitates removal of RNA and homologous recombination at DNA double-strand breaks. Mol Cell Biol 36(22):2794\u20132810","journal-title":"Mol Cell Biol"},{"issue":"8","key":"1719_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102180","volume":"298","author":"L Li","year":"2022","unstructured":"Li L, Garg M, Wang Y, Wang W, Godbout R (2022) DEAD box 1 (DDX1) protein binds to and protects cytoplasmic stress response mrnas in cells exposed to oxidative stress. J Biol Chem 298(8):102180","journal-title":"J Biol Chem"},{"issue":"17","key":"1719_CR19","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-21-3748","volume":"82","author":"T Liu","year":"2022","unstructured":"Liu T, Gan H, He S, Deng J, Hu X, Li L et al (2022) RNA helicase DDX24 stabilizes LAMB1 to promote hepatocellular carcinoma progression. Cancer Res 82(17):3074\u20133087","journal-title":"Cancer Res"},{"issue":"3","key":"1719_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/cas.16076","volume":"115","author":"J Liu","year":"2024","unstructured":"Liu J, Yang T, Luo Y, Ma Z, Yu Z, Zhang L et al (2024) DEAD-box helicase 1 inhibited CD8(+) T cell antitumor activity by inducing PD-L1 expression in hepatocellular carcinoma. Cancer Sci 115(3):763\u2013776","journal-title":"Cancer Sci"},{"issue":"12","key":"1719_CR21","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/j.molcel.2025.05.015","volume":"85","author":"T Liu","year":"2025","unstructured":"Liu T, Yang D, Wei Q, Wang Y, Tian L, Liu X et al (2025a) The RNA-stability-independent role of the RNA m(6)A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance. Mol Cell 85(12):2320\u201336e9","journal-title":"Mol Cell"},{"issue":"17","key":"1719_CR22","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/hmg\/ddaf110","volume":"34","author":"S Liu","year":"2025","unstructured":"Liu S, Zhang S, Zhao H, Liu Y, Zhang Z, Geng X et al (2025b) The RNA-binding protein DDX39B promotes colorectal adenocarcinoma progression by stabilizing DCLK1. Hum Mol Genet 34(17):1495\u20131504. https:\/\/doi.org\/10.1093\/hmg\/ddaf110","journal-title":"Hum Mol Genet"},{"issue":"12","key":"1719_CR23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S1470-2045(23)00469-2","volume":"24","author":"JM Llovet","year":"2023","unstructured":"Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M et al (2023) Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial. Lancet Oncol 24(12):1399\u20131410","journal-title":"Lancet Oncol"},{"key":"1719_CR24","doi-asserted-by":"crossref","unstructured":"Ma S, Meng G, Liu T, You J, He R, Zhao X et al (2024) The Wnt signaling pathway in hepatocellular carcinoma: regulatory mechanisms and therapeutic prospects, vol 180. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie, p 117508","DOI":"10.1016\/j.biopha.2024.117508"},{"issue":"5","key":"1719_CR25","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.3390\/ijms23052761","volume":"23","author":"SP Papadakos","year":"2022","unstructured":"Papadakos SP, Petrogiannopoulos L, Pergaris A, Theocharis S (2022) The EPH\/ephrin system in colorectal cancer. Int J Mol Sci 23(5):2761. https:\/\/doi.org\/10.3390\/ijms23052761","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1719_CR26","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s41419-018-1164-y","volume":"9","author":"Q Peng","year":"2018","unstructured":"Peng Q, Chen L, Wu W, Wang J, Zheng X, Chen Z et al (2018) EPH receptor A2 governs a feedback loop that activates Wnt\/\u03b2-catenin signaling in gastric cancer. Cell Death Dis 9(12):1146","journal-title":"Cell Death Dis"},{"issue":"16","key":"1719_CR27","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.3390\/ijms22168412","volume":"22","author":"A Pergaris","year":"2021","unstructured":"Pergaris A, Danas E, Goutas D, Sykaras AG, Soranidis A, Theocharis S (2021) The clinical impact of the EPH\/Ephrin system in cancer: unwinding the thread. Int J Mol Sci 22(16):8412. https:\/\/doi.org\/10.3390\/ijms22168412","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1719_CR28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM (2023) Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol 20(12):864\u2013884","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1719_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y et al (2024) Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol 17(1):46","journal-title":"J Hematol Oncol"},{"issue":"8","key":"1719_CR30","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/cas.13661","volume":"109","author":"K Tanaka","year":"2018","unstructured":"Tanaka K, Ikeda N, Miyashita K, Nuriya H, Hara T (2018) DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene. Cancer Sci 109(8):2479\u20132489","journal-title":"Cancer Sci"},{"issue":"7","key":"1719_CR31","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1111\/jcmm.15036","volume":"24","author":"L Wang","year":"2020","unstructured":"Wang L, Song Y, Wang H, Liu K, Shao Z, Shang Z (2020a) MiR-210-3p-EphrinA3-PI3K\/AKT axis regulates the progression of oral cancer. J Cell Mol Med 24(7):4011\u20134022","journal-title":"J Cell Mol Med"},{"key":"1719_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2125656","volume":"2020","author":"H Wang","year":"2020","unstructured":"Wang H, Wang L, Zhou X, Luo X, Liu K, Jiang E et al (2020b) OSCC exosomes regulate miR-210-3p targeting EFNA3 to promote oral cancer angiogenesis through the PI3K\/AKT pathway. BioMed Res Int 2020:2125656","journal-title":"BioMed Res Int"},{"issue":"6","key":"1719_CR33","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","volume":"164","author":"J Wang","year":"2023","unstructured":"Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W et al (2023) N6-methyladenosine-mediated up-regulation of FZD10 regulates liver cancer stem cells\u2019 properties and lenvatinib resistance through WNT\/\u03b2-catenin and Hippo signaling pathways. Gastroenterology 164(6):990\u20131005","journal-title":"Gastroenterology"},{"issue":"2","key":"1719_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-024-01321-2","volume":"24","author":"P Wang","year":"2024","unstructured":"Wang P, Yang L, Guo Y, Qi S, Liang J, Tian G et al (2024) Senp3 mediates the activation of the Wnt\/\u03b2-catenin signaling pathway to accelerate the growth and metastasis of oesophagal squamous cell carcinoma in mice. Funct Integr Genomics 24(2):40","journal-title":"Funct Integr Genomics"},{"key":"1719_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121592","volume":"323","author":"Q Yang","year":"2023","unstructured":"Yang Q, Xu P, Liu Q, Hu F, Xie X, Jiang L et al (2023) Depleting DDX1 sensitizes non-small cell lung cancer cells to chemotherapy by attenuating cancer stem cell traits. Life Sci 323:121592","journal-title":"Life Sci"},{"issue":"1","key":"1719_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12865-022-00533-0","volume":"23","author":"M Yuan","year":"2022","unstructured":"Yuan M, Xu J, Cao S, Sun S (2022) DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma. BMC Immunol 23(1):59","journal-title":"BMC Immunol"},{"key":"1719_CR37","doi-asserted-by":"publisher","first-page":"796592","DOI":"10.3389\/fgene.2021.796592","volume":"12","author":"P Zheng","year":"2021","unstructured":"Zheng P, Liu X, Li H, Gao L, Yu Y, Wang N et al (2021) EFNA3 is a prognostic biomarker correlated with immune cell infiltration and immune checkpoints in gastric cancer. Front Genet 12:796592","journal-title":"Front Genet"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01719-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01719-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01719-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:06:05Z","timestamp":1769155565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01719-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01719-6","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants was reviewed and approved by the Second Affiliated Hospital of Nanchang University Medical Research Ethics Committee (Ethics ID: [2021] No.(005)). The patients\/participants provided written informed consent to participate in this study. All animal experiments were approved by the Institutional Animal Care and Use Committee of Nanchang Royo Biotech Co,. Ltd (Ethics ID: RYE2023120301). This study is conducted in accordance with the Helsinki Declaration and ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\u00a0statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure\u00a0statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}